Warfarin Increases Stroke Risk in Atrial Fibrillation Patients

Published Online: Tuesday, January 14, 2014
A study published in the European Heart Journal finds that atrial fibrillation patients were more likely to suffer a stroke within the first month of initiating treatment with warfarin when compared with those not using any antithrombotic therapy. Data on stroke incidence in patients newly diagnosed with atrial fibrillation was analyzed and each case of stroke was randomly matched with 10 controls. Stroke risk was significantly higher among patients who had begun taking warfarin within 30 days when compared with patients who had not used any antithrombotic therapy for at least 1 year. Patients taking warfarin had a lower risk for stroke when they had been taking the drug longer than 1 month.

To read the full article on HCPLive.com, click here.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$